Liang Zheng

Prof. Dr. Liang Zheng


Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2024 in Cardiovascular Diabetology
Verified
Journal Article
Open access
PDF file
WLWeipeng Li
Weipeng Li
CSChaonan Shen
Chaonan Shen
WKWeiya Kong
Weiya Kong
XZXiaohui Zhou
Xiaohui Zhou
HFHuimin Fan
Huimin Fan
LZLiang Zheng
Liang Zheng
Background: The American Heart Association (AHA) has recently introduced the concept of Cardiovascular-Kidney-Metabolic (CKM) syndrome, which is the result of an increasing emphasis on the interplay of metabolic, renal and cardiovascular diseases (CVD). Furthermore, there is substantial evidence of a correlation between the triglyceride glucose-body mass index (TyG-BMI ) and CVD as an assessment of insulin resistance (IR). However, it remains unknown whether this correlation exists in population with CKM syndrome. Methods: All data for this study were obtained from the China Health and Retirement Longitudinal Study (CHARLS). The exposure was the participants’ TyG-BMI at baseline, which was calculated using a combination of triglycerides (TG), fasting blood glucose (FBG) and body mass index (BMI). The primary outcome was CVD, which were determined by the use of a standardised questionnaire during follow-up. To examine the relationship between TyG-BMI and CVD incidence in population with CKM syndrome, both Cox regression analyses and restricted cubic spline (RCS) regression analyses were performed. Results: A total of 7376 participants were included in the final analysis. Of these, 1139, 1515, 1839, and 2883 were in CKM syndrome stages 0, 1, 2, and 3, respectively, at baseline. The gender distribution was 52.62% female, and the mean age was 59.17 ± 9.28 (years). The results of the fully adjusted COX regression analyses indicated that there was a 6.5% increase in the risk of developing CVD for each 10-unit increase in TyG-BMI,95% confidence interval (CI):1.041–1.090. The RCS regression analyses demonstrated a positive linear association between TyG-BMI and the incidence of CVD in the CKM syndrome population (P for overall < 0.001, P for nonlinear = 0.355). Conclusions: This cohort study demonstrated a positive linear association between TyG-BMI index and increased CVD incidence in a population with CKM syndrome stage 0–3. This finding suggests that enhanced assessment of TyG-BMI index may provide a more convenient and effective tool for individuals at risk for CVD in CKM syndrome stage 0–3.

13 March 2019 in Obesity Reviews
Verified
Journal Article
Closed access
PDF file
RZRulin Zhuang
Rulin Zhuang
XGXinyu Ge
Xinyu Ge
LHLu Han
Lu Han
PYPing Yu
Ping Yu
XGXin Gong
Xin Gong
XZXiaohui Zhou
Xiaohui Zhou

13 May 2021 in Journal of Diabetes Investigation
Verified
Journal Article
Open access
PDF file
YLYaxin Li
Yaxin Li
AYAijun You
Aijun You
BTBrian Tomlinson
Brian Tomlinson
LYLongfei Yue
Longfei Yue
KZKanjie Zhao
Kanjie Zhao
LZLiang Zheng
Liang Zheng
Aims/Introduction: To compare the association of hypertension plus hyperuricemia with four insulin resistance surrogates, including glucose and triglycerides (TyG index), TyG index with body mass index (TyG‐BMI), the ratio of triglycerides divided by high‐density lipoprotein cholesterol (TG/HDL‐C) and metabolic score for insulin resistance (METS‐IR).Materials and Methods: Data from a cross‐sectional epidemiological study enrolling a representative population sample aged ≥65 years were used to calculate the four indexes. The association with hypertension plus hyperuricemia and insulin resistance surrogates was examined with multivariate logistic regression and receiver operating characteristic.Results: A total of 4,352 participants were included, including 93 (2.1%) patients with hyperuricemia alone, 2,875 (66.1%) with hypertension alone and 587 (13.5%) with hypertension plus hyperuricemia. Mutivariate logistic regression showed that TyG index, TyG‐BMI, TG/HDL‐C and METS‐IR were all significantly correlated with hyperuricemia, hypertension and hypertension plus hyperuricemia. Compared with the lowest quartile, the odds ratios (OR) of the highest quartile of the four indicators for hypertension plus hyperuricemia were TyG index: OR 6.39 (95% confidence interval [CI] 4.17–9.78); TyG‐BMI: OR 8.54 (95% CI 5.58–13.09); TG/HDL‐C: OR 7.21 (95% CI 4.72–11.01); METS‐IR: OR 9.30 (95% CI 6.00–14.43), respectively. TyG‐BMI and METS‐IR had moderate discriminative abilities for hypertension plus hyperuricemia and the AUC values were 0.72 (95% CI 0.70–0.74) and 0.73 (95% CI 0.70–0.75).Conclusions: The present study suggested that TyG index, TyG‐BMI, TG/HDL‐C and METS‐IR had a significant correlation with hypertension plus hyperuricemia, and TyG‐BMI and METS‐IR had discriminative abilities for hypertension plus hyperuricemia.

1 January 2018 in Journal of Cancer
Verified
Journal Article
Open access
SBShiva Basnet
Shiva Basnet
QLQi-Feng Lou
Qi-Feng Lou
NLNan Liu
Nan Liu
RRRamesh Rana
Ramesh Rana
ASAbilasha Shah
Abilasha Shah
HGHai-Yan Ge
Hai-Yan Ge
Background: Tumor deposits are one of the promising factors among the different edition of Tumor, Node, Metastasis classification. Despite improvement in the treatment of various types of metastatic disease the source and prognostic significance of tumor deposits in staging has not been deliberating the agreeable opinion. We investigated the possibility of tumor deposit as independent prognostic factor and evaluating its prognostic value in colorectal carcinoma patients.

5 September 2024 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
JDJiaxing Dong
Jiaxing Dong
WJWanju Jiang
Wanju Jiang
WZWenjia Zhang
Wenjia Zhang
TGTaohua Guo
Taohua Guo
YYYucheng Yang
Yucheng Yang
TDTao Du
Tao Du
Background: The recent hemoglobin, albumin, lymphocyte, and platelet (HALP) scores, combined with various clinically available indicators, can comprehensively evaluate the nutritional and immune status of patients. Some observational studies have found a positive correlation between HALP score and cancer prognosis, but the clinical application of HALP score has raised concerns due to the presence of confounding factors. The aim of this study is to explore the relationship between HALP score and long-term mortality in cancer patients.Methods: We extracted 3832 cancer patients with complete baseline information from the National Health and Nutrition Examination Survey (NHANES). The COX regressions and restricted cubic spline (RCS) curves were used to explore the nonlinear relationship between HALP score and long-term mortality risk in cancer patients. Kaplan-Meier (K-M) curve was conducted to evaluate the impact of HALP score on long-term mortality risk. Additionally, subgroup analysis was conducted to verify the stability of the above results.Results: We divided participants into 4 groups based on HALP score, and the COX regression results showed that risk of long-term mortality tended to be lower in cancer patients with high HALP scores. Meanwhile, the RCS curves showed that there was a nonlinear association. The results remained stable in subgroup analyses and in breast cancer, colorectal cancer, cervix and uterus cancer, melanoma, prostate cancer and skin cancer.Conclusions: HALP score were independently associated with the risk of long-term mortality in cancer patients, and there is also a non-linear association. This will provide new perspectives on clinical and nutritional interventions for cancer patients.

10 February 2022 in Frontiers in Cardiovascular Medicine
Verified
Journal Article
Open access
CLChang Liu
Chang Liu
LLLiping Liu
Liping Liu
YWYinglu Wang
Yinglu Wang
XCXiaoli Chen
Xiaoli Chen
JLJie Liu
Jie Liu
YZYuzhen Zhang
Yuzhen Zhang
Background: Hyperhomocysteinemia (HHcy) and abdominal obesity are risk factors for metabolic syndrome (MetS) and death from cardiovascular disease (CVD). Recent studies have shown a correlation between HHcy and abdominal obesity, suggesting that they may have a combined effect on the risk of MetS and CVD mortality. However, this suspicion remains to be confirmed, particularly in the elderly population. We explored their combined effects on the risk of MetS and CVD mortality among the community population aged 65 and above in China. Methods and Results: This prospective study enrolled 3,675 Chinese community residents aged 65 and above in May 2013 with 7-year follow-up of all-cause and CVD mortality. HHcy was defined as the blood homocysteine (Hcy) level >15 μmol/L and abdominal obesity as waist circumference (WC) ≥90 cm for men and ≥80 cm for women (HWC). All participants were grouped into four categories by WC and the blood level of Hcy: NWC (normal WC) /HHcy(–), NWC/HHcy(+), HWC/HHcy(–), and HWC/HHcy(+). The relationship of combined HHcy and abdominal obesity with MetS and metabolic profile was evaluated by logistic regression analysis and the association of combined HHcy and abdominal obesity with CVD and all-cause mortality evaluated by Cox regression analysis. The prevalence of HHcy, abdominal obesity and MetS in elderly Chinese community residents was 40.1, 59.3, and 41.4%, respectively. Using group without HHcy and abdominal obesity [NWC/HHcy(–)] as reference, the participants of other three groups had significantly higher risk of MetS and its component abnormalities, with HWC/HHcy(+) group having the highest risk (OR = 13.52; 95% CI = 8.61–14.55). After a median of 6.94 (±1.48) years follow-up, 454 deaths occurred with 135 CVD deaths. Compared with NWC/HHcy(–) group, the risk of 7-year follow-up CVD mortality (HR = 1.75; 95% CI = 1.02–3.03) and all-cause mortality (HR = 1.23; 95% CI = 1.04–2.18) of HWC/HHcy(+) group increased considerably after adjustment for major MetS and CVD risk factors. Conclusions: There is high prevalence of HHcy, abdominal obesity, and MetS in the elderly Chinese community population. HHcy increases risk of MetS, CVD, and all-cause mortality, especially in the populations with abdominal obesity.